Physician profile
Laurie E Davis
NPI 1205937836
$2,412.12
in general payments reported to CMS, 2019-2025
16 companies · $807 in 2025
The $807 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.28 · 2022: $72.11 · 2023: $422 · 2024: $1,081 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,309.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $958.07 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Collegium Pharmaceutical, INC. | $680.45 | 2023-2025 | Belbuca, Xtampza |
| Abbvie INC. | $230.12 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.54 | 2025 | Relistor |
| Nevro Corp. | $124.92 | 2022-2024 | Senza |
| Lundbeck LLC | $39.52 | 2023 | Vyepti |
| Tonix Medicines, INC. | $37.80 | 2025 | Tonmya |
| Emd Serono, INC. | $30.28 | 2021 | |
| Spr Therapeutics, INC | $30.08 | 2024 | Sprint Pns System |
| Painteq LLC | $28.91 | 2023 | Painteq |
| Vertex Pharmaceuticals Incorporated | $28.49 | 2025 | |
| Amneal Pharmaceuticals LLC | $24.88 | 2023 | Lyvispah |
| Nalu Medical, INC. | $19.27 | 2024 | Nalu Neurostimulation System |
| Alexion Pharmaceuticals, INC. | $16.52 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.30 | 2023 | Horizant |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.97 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.